The US Court of Appeals for the Federal Circuit upheld the PTAB’s decision to invalidate AliveCor’s patents for ECG monitoring technologies, emphasizing the importance of demonstrating non-obviousness and substantial technological advancement in patent claims within the AI healthtech sector.
View full story…